These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30975547)
1. Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan. Otta-Oshiro RJ; Lista-Mateos F; García-Mediero J; Arranz-Arija JA; García-Prado J; Núñez-Mora C Actas Urol Esp (Engl Ed); 2019; 43(6):331-335. PubMed ID: 30975547 [TBL] [Abstract][Full Text] [Related]
2. Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. Bravi CA; Fossati N; Gandaglia G; Suardi N; Mazzone E; Robesti D; Osmonov D; Juenemann KP; Boeri L; Jeffrey Karnes R; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A Eur Urol; 2020 Dec; 78(6):779-782. PubMed ID: 32624281 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959 [TBL] [Abstract][Full Text] [Related]
4. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes. Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163 [TBL] [Abstract][Full Text] [Related]
5. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management. Linxweiler J; Sprenk J; Cascetta K; Pryalukhin A; Hölters S; Zeuschner P; Nini A; Al-Kailani Z; Ezziddin S; Bohle RM; Fries P; Ohlmann CH; Heinzelbecker J; Siemer S; Stöckle M; Junker K; Saar M J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326 [TBL] [Abstract][Full Text] [Related]
6. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy. Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893 [TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Bravi CA; Fossati N; Gandaglia G; Suardi N; Mazzone E; Robesti D; Osmonov D; Juenemann KP; Boeri L; Jeffrey Karnes R; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A Eur Urol; 2020 Nov; 78(5):661-669. PubMed ID: 32624288 [TBL] [Abstract][Full Text] [Related]
8. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up. Winter A; Henke RP; Wawroschek F BMC Urol; 2015 Feb; 15(1):10. PubMed ID: 25881245 [TBL] [Abstract][Full Text] [Related]
9. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Rigatti P; Suardi N; Briganti A; Da Pozzo LF; Tutolo M; Villa L; Gallina A; Capitanio U; Abdollah F; Scattoni V; Colombo R; Freschi M; Picchio M; Messa C; Guazzoni G; Montorsi F Eur Urol; 2011 Nov; 60(5):935-43. PubMed ID: 21840116 [TBL] [Abstract][Full Text] [Related]
10. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322 [TBL] [Abstract][Full Text] [Related]
11. Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by Devos G; Witters M; Moris L; Van den Broeck T; Berghen C; Devlies W; De Meerleer G; Goffin K; Jentjens S; Albersen M; Van Poppel H; Everaerts W; Joniau S World J Urol; 2021 Feb; 39(2):399-406. PubMed ID: 32417995 [TBL] [Abstract][Full Text] [Related]
12. PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis. Schmidt-Hegemann NS; Buchner A; Eze C; Rogowski P; Schaefer C; Ilhan H; Li M; Fendler WP; Bartenstein P; Ganswindt U; Stief C; Belka C; Kretschmer A Strahlenther Onkol; 2020 Jul; 196(7):637-646. PubMed ID: 32211942 [TBL] [Abstract][Full Text] [Related]
13. Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. Steuber T; Jilg C; Tennstedt P; De Bruycker A; Tilki D; Decaestecker K; Zilli T; Jereczek-Fossa BA; Wetterauer U; Grosu AL; Schultze-Seemann W; Heinzer H; Graefen M; Morlacco A; Karnes RJ; Ost P Eur Urol Focus; 2019 Nov; 5(6):1007-1013. PubMed ID: 29530632 [TBL] [Abstract][Full Text] [Related]
14. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy. Yoo S; You D; Kim YS; Hong JH; Ahn H; Kim CS Urol Int; 2017; 99(4):406-413. PubMed ID: 29020683 [TBL] [Abstract][Full Text] [Related]
15. Management of positive lymph nodes following radical prostatectomy. Heidenreich A; Rieke M; Mahjoub S; Pfister D Arch Esp Urol; 2019 Mar; 72(2):182-191. PubMed ID: 30855020 [TBL] [Abstract][Full Text] [Related]
16. Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy. Van Eecke H; Devos G; Vansevenant B; Vander Stichele A; Devlies W; Berghen C; Everaerts W; De Meerleer G; Joniau S Int J Urol; 2023 Jan; 30(1):92-99. PubMed ID: 36305586 [TBL] [Abstract][Full Text] [Related]
17. Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy. Tilki D; Mandel P; Seeliger F; Kretschmer A; Karl A; Ergün S; Seitz M; Stief CG J Urol; 2015 Feb; 193(2):484-90. PubMed ID: 25180792 [TBL] [Abstract][Full Text] [Related]
18. Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of Fossati N; Scarcella S; Gandaglia G; Suardi N; Robesti D; Boeri L; Karnes RJ; Heidenreich A; Pfister D; Kretschmer A; Buchner A; Stief C; Battaglia A; Joniau S; Van Poppel H; Osmonov D; Juenemann KP; Shariat S; Hiester A; Nini A; Albers P; Tilki D; Graefen M; Gill IS; Mottrie A; Galosi AB; Montorsi F; Briganti A J Urol; 2020 Aug; 204(2):296-302. PubMed ID: 32068488 [TBL] [Abstract][Full Text] [Related]